ANI Pharmaceuticals | ANIP - EPS Earnings Per Share


ANI Pharmaceuticals reported $2.7 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 2.70 2.50 2.04 Nov/05
FY2026Q2 Jun/2026 2.21 2.03 1.80 Aug/07
FY2026Q1 Mar/2026 2.05 1.58 1.70 May/08
FY2025Q4 Dec/2025 2.33 1.97 1.63 Feb/27
FY2025Q3 Sep/2025 2.04 1.71 1.34 Nov/07




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
ANI Pharmaceuticals USD 2.7 0.49 Sep/2026
Aurora Cannabis CAD -0.07 0.06 Jun/2026
Canopy Growth CAD -0.03 0.37 Jun/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Heron Therapeutics USD -0.02 0.02 Dec/2025
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Novartis USD 0.63 1.36 Sep/2026
Omeros USD -1.12 0.37 Jun/2024
Perrigo USD 0.6 0.1 Sep/2026
Sun Pharmaceuticals INR 13.2 0.09 Sep/2026
Teva Pharmaceutical Industries USD 0.79 0.73 Sep/2026